Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hisashi Shinohara is active.

Publication


Featured researches published by Hisashi Shinohara.


Cornea | 2004

Rebamipide increases the amount of mucin-like substances on the conjunctiva and cornea in the n-acetylcysteine-treated in vivo model

Hiroki Urashima; Takashi Okamoto; Yasuhiro Takeji; Hisashi Shinohara; Shigeki Fujisawa

Purpose: Rebamipide increases the amount of mucin-like substances in the stomach. We aimed to determine the effects of rebamipide on the amount of mucin-like substances in the conjunctiva and cornea of N-acetylcysteine-treated eyes. Furthermore, we attempted to evaluate the effects of rebamipide on the wound healing of N-acetylcysteine-treated eyes. Methods: The model was created by instilling 10% N-acetylcysteine solutions into rabbit eyes. Rebamipide was then applied on the day following the completion of N-acetylcysteine treatment. The amount of mucin-like substances on the conjunctiva and cornea was measured using the Alcian-blue binding method. The degree of damage was evaluated using scores based on the areas and densities of the cornea and conjunctival after staining using a rose Bengal solution under blind conditions. Results: Rebamipide increased the level of mucin-like substances on the conjunctiva of N-acetylcysteine-treated eyes when instilled at concentrations of 0.3% or higher, and 1% rebamipide increased the amount of mucin-like substances covering the cornea. Moreover, 1% rebamipide improved the rose Bengal scores of the cornea and conjunctiva in N-acetylcysteine-treated eyes. Conclusions: Rebamipide increased mucin-like substances on the cornea and conjunctiva of N-acetylcysteine-treated eyes. In accordance with the mucin-increasing effects, rebamipide improved the rose Bengal scores for the cornea and conjunctiva of N-acetylcysteine-treated eyes. However, the relevance of these findings to dry eyes is unclear because it is not known whether the change in mucus expression in the N-acetylcysteine model is similar to what occurs in aqueous tear deficiency. Consequently, it may be worth trying on an animal model of keratoconjunctivitis sicca.


Journal of Ocular Pharmacology and Therapeutics | 2012

Rebamipide Increases Mucin-Like Substance Contents and Periodic Acid Schiff Reagent-Positive Cells Density in Normal Rabbits

Hiroki Urashima; Yasuhiro Takeji; Takashi Okamoto; Shigeki Fujisawa; Hisashi Shinohara

PURPOSE The effects of rebamipide on the number of periodic acid Schiff reagent (PAS)-positive cells in the conjunctiva, the mucin content in the cornea and conjunctiva of normal rabbits, and desiccation-induced corneal damage in vivo were examined. METHODS Rebamipide (0.1%-3%) was applied 6 times a day for 14 days, and the PAS-positive cell count in the bulbar conjunctiva was measured by impression cytology. The amount of conjunctival and corneal mucin-like substances was measured by Alcian blue binding. The corneal damage model was created by desiccation from air flow at room temperature. The level of corneal damage was determined by scoring the area stained with rose bengal and fluorescein dye. RESULTS Rebamipide increased the number of PAS-positive cells in the conjunctiva when instilled at concentrations of 0.3% or higher, and 1% rebamipide increased the amount of mucin-like substances of the conjunctiva and cornea. Moreover, 1% rebamipide was also found to lower the rose bengal scores of the cornea in the corneal damage model by desiccation. CONCLUSIONS Rebamipide is a possible candidate drug for treatment of cornea and conjunctival epithelial damage due to its mucin-like substance increasing action, for instance, in the treatment of dry eye disease.


Journal of Ocular Pharmacology and Therapeutics | 2012

Rebamipide Increases the Mucin-Like Glycoprotein Production in Corneal Epithelial Cells

Yasuhiro Takeji; Hiroki Urashima; Akihiro Aoki; Hisashi Shinohara

PURPOSE Dry eye is a multifactorial disease of tears and the ocular surface due to tear deficiency or excessive tear evaporation. Tear film instability is due to a disturbance in ocular surface mucin leading to a dysfunction of mucin, resulting in dry eye. In this study, we examined the effect of rebamipide, an anti-ulcer agent, on glycoconjugate production, as an indicator of mucin-like glycoprotein in cultured corneal epithelial cells. Further, we investigated the effect of rebamipide on the gene expression of membrane-associated mucins. METHODS Confluent cultured human corneal epithelial cells were incubated with rebamipide for 24 h. The glycoconjugate content in the supernatant and the cell extracts was measured by wheat germ agglutinin-enzyme-linked lectin assay combined gel-filtration method. In the experiment on mucin gene expression, cultured human corneal epithelial cells were collected at 0, 3, 6, and 12 h after administration of rebamipide. Real-time quantitative polymerase chain reaction was used to analyze the quantity of MUC1, MUC 4, and MUC16 gene expression. RESULTS Rebamipide significantly increased the glycoconjugate contents in the supernatant and cell extract. In the mucin gene expression in the cells, rebamipide increased MUC1 and MUC4 gene expression, but did not increase MUC16 gene expression. CONCLUSIONS Rebamipide promoted glycoconjugate, which has a property as a mucin-like glycoprotein, in human corneal epithelial cells. The increased production was mediated by MUC1 and MUC4 gene expression.


Current Eye Research | 2014

Regulation of Human Corneal Epithelial Mucins by Rebamipide

Shinsaku Itoh; Kuni Itoh; Hisashi Shinohara

Abstract Purpose: Membrane-associated mucins (MAMs) play important roles in barrier function and tear stability, and their expression on the ocular surface is altered in dry eye disease. Rebamipide is a mucin secretagogue that promotes the production of mucin-like glycoproteins in human corneal epithelial (HCE) cells. However, the expression of MAMs on the corneal epithelia (MUC1, MUC4, MUC16), which is induced by rebamipide, is poorly understood. In this study, we investigated the effect of rebamipide on the regulation of MAM expression in HCE cells. Materials and Methods: MUC16, Ki67 and PCNA expression levels in HCE cells isolated at confluence and at 24 hours after confluence were examined by Western blotting to assess cell proliferation. HCE cells isolated at 24 hours after confluence were cultured in medium supplemented with 1–10 µM rebamipide or 0.3–30 nM of epidermal growth factor (EGF). Real-time PCR (RT-PCR) and Western blot analysis of MAMs were performed to evaluate the effect of rebamipide. Western blot analysis of cells treated with an EGF receptor inhibitor (AG1478) or MEK1/2 inhibitor (U0126) was performed to reveal the relationship between EGF receptor activation and rebamipide-induced MAM expression. Results: HCE cells isolated at 24 hours after confluence had lower cell proliferation activity and increased MUC16 expression compared with cells isolated at confluence. RT-PCR and Western blot analysis revealed that rebamipide increased MAM gene expression for 2 hours and protein expression for 24 hours in HCE cells. EGF inhibitor treatment led to reduced levels of all three MAMs that are normally induced by rebamipide, whereas EGF induced the expression of all three MAMs. Conclusions: We suggested that rebamipide increased MUC1, MUC4 and MUC16 expression levels through signals involved in EGF receptor activation in the human corneal epithelia. These data suggest that rebamipide may improve subjective symptoms of dry eye disease by upregulating MAM expression.


Current Eye Research | 2013

Investigation of Capsaicin-induced Superficial Punctate Keratopathy Model Due to Reduced Tear Secretion in Rats

Yoto Kagawa; Shinsaku Itoh; Hisashi Shinohara

ABSTRACT Purpose: The present study investigated the usefulness of the superficial punctate keratopathy (SPK) model due to reduced tear secretion induced by the injection of capsaicin in neonatal rats. Methods: On postnatal day 4, rats were injected subcutaneously with a single dose of capsaicin. Ocular surface symptoms were evaluated by measuring corneal sensitivity, tear secretion and corneal fluorescein score. Furthermore, the effect of pilocarpine was investigated by measuring tear secretion and corneal fluorescein score in this model. The influence of discontinuation of pilocarpine application was also examined. Results: Capsaicin caused a dose-dependent reduction of tear secretion and increase of corneal fluorescein score. In addition, 50 mg/kg capsaicin-treated rats showed a sustained decrease of corneal sensitivity and tear secretion, and an increase of corneal fluorescein score compared with vehicle-treated rats. Moreover, capsaicin-treated rats showed SPK. Instillation of pilocarpine significantly increased tear secretion and tended to improve the corneal fluorescein score by repeated application, whereas tear secretion and corneal fluorescein score in the pilocarpine-treated rats returned to the same level as that of capsaicin-treated rats after discontinuation of pilocarpine application. Conclusions: Injection of capsaicin in rats induced stable SPK due to reduced tear secretion accompanied by a decrease of corneal sensitivity. Thus, it may be concluded that this model is essentially similar to SPK due to reduced tear secretion and could be used in the development of appropriate new drugs for therapy.


Archive | 1996

Carbostyril derivative for curing ophthalmological diseases

Hiroki Urashima; Yasuhiro Takeji; Hisashi Shinohara; Shigeki Fujisawa


Archive | 2005

4-Amino-5-Cyanopyrimidine Derivatives

Masaya Kato; Norifumi Sato; Minoru Okada; Tetsuyuki Uno; Nobuaki Ito; Yasuhiro Takeji; Hisashi Shinohara; Masahiro Fuwa


Archive | 2012

MEDICAMENT FOR TREATING ANTERIOR EYE DISEASE COMPRISING REBAMIPIDE AND A TEAR-RETAINING AGENT

Yasuhiro Takeji; Hideo Nakashima; Hiroki Urashima; Hisashi Shinohara; Yuki Hirata


Investigative Ophthalmology & Visual Science | 2002

OPC-12759 Ophthalmic Suspension Increases the Ocular Mucin of Rabbits

Hiroki Urashima; Hisashi Shinohara; K. Fujita; Shigeki Fujisawa


Archive | 2010

A NOVEL CYANOPYRIMIDINE DERIVATIVE

Norifumi Sato; Yohei Yuki; Hisashi Shinohara; Yasuhiro Takeji; Kuni Ito; Daisaku Michikami; Keisuke Hino; Hiroyuki Yamazaki

Collaboration


Dive into the Hisashi Shinohara's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge